Risk factors and outcome of COVID-19 in patients with hematological malignancies
2020 · Experimental Hematology and Oncology · 152 citations
https://doi.org/10.1186/s40164-020-00177-z
L
Lourdes Vázquez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
232
Papers
6.0K
Citations
43
h-index
125
i10-index
Lourdes Vázquez is an academic researcher from Universidad de Salamanca. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Antifungal resistance and susceptibility & Fungal Infections and Studies. The author has an h-index of 43, co-authored 198 publications.
ORCID: 0000-0001-8191-0046Papers by this author
worksMultidisciplinary consensus on the criteria for fertility preservation in cancer patients
2021 · Clinical & Translational Oncology · 56 citations
https://doi.org/10.1007/s12094-021-02699-2
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
2021 · Journal of Infection · 46 citations
https://doi.org/10.1016/j.jinf.2021.07.014
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
2022 · Journal of Hematology & Oncology · 38 citations
https://doi.org/10.1186/s13045-022-01275-7
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium
2020 · Journal of Fungi · 37 citations
https://doi.org/10.3390/jof7010004
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
2023 · Blood Cancer Journal · 31 citations
https://doi.org/10.1038/s41408-022-00778-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat